Provider credentialing & network · CVO and sanction screening
Verisys
Verisys is a credentials verification organization that checks provider licenses, sanctions and credentials for health plans, hospitals and pharmacies, with its FACIS exclusion database.
Strong fit
- Health plans and large networks that want to outsource credentialing to a certified CVO
- Pharmacies and telehealth companies that need sanction and license monitoring
- Compliance teams that want one source for exclusion data
Weak fit
- Small practices that credential a few providers a year
- Buyers who want a posted price
- Teams that want published turnaround data
Bottom line
Verisys is a reasonable choice for health plans, pharmacies and large networks that want an NCQA-certified CVO with deep sanction and license data. It suits buyers that can negotiate a contract and test turnaround times first. Smaller groups and buyers who want posted prices or published results should look elsewhere.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Former federal health officials John O'Shaughnessy and Dick Kusserow started the company in 1992 in Alexandria, Virginia, as Government Management Services. It created FACIS, a database of excluded and sanctioned providers, and became Verisys after John Benson joined in 2007.
Verisys merged with Aperture Health in 2021 under the private equity firm Stone Point Capital and later bought Med Advantage. The combined company is based in Louisville, Kentucky, with Benson as chairman and Amy Andersen and Eric Gwynn as co-presidents.
Verisys is a credentials verification organization, or CVO. It checks a provider's licenses, certifications, education and sanctions with the original sources so health plans and hospitals can approve that provider. It holds NCQA certification and URAC accreditation and handles more than two million outsourced credentialing events a year.
Its tools include FACIS for exclusion screening, CheckMedic for credentialing and provider data, and ProviderCheck for real-time checks on prescribers. Clients include health plans, hospitals, retail pharmacies, telehealth companies and state Medicaid agencies, and Verisys says it has served more than 1,000 of them.
Andros and Medversant fit health plans that want to compare other CVOs. CertifyOS and Verifiable fit teams that want credentialing software they run themselves, and ProviderTrust fits when exclusion and license monitoring is the main need.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| CertifyOS | 7.7 | 7.4 |
| Andros | 7.6 | 7.3 |
| Verifiable | 7.1 | 6.9 |
| ProviderTrust | 6.8 | 6.6 |
| Medversant | 6.7 | 6.4 |
| Verisys | 6.7 | 6.9 |
Pricing
| Item | Detail |
|---|---|
| Model | Verisys prices credentialing, screening and monitoring by contract. |
| What usually drives cost | For Verisys, cost depends on the number of providers, how many checks each one needs, and whether Verisys runs the whole credentialing process. |
| What to ask before you buy | Ask Verisys for its turnaround time by provider type, its price per credentialing file and per monitored provider, and how it fixes data errors. |
| Published pricing | Verisys does not publish a price list. |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.